CIK 0000887359 · Large accelerated filer
Vericel Corp
Sign in to watch- Ticker
- VCEL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- MI
- Entity type
- operating
- EIN
- 943096597
- Phone
- 6175885555
- Business address
- 25 BLUE SKY DRIVE, BURLINGTON, MA, 01803
- Former names
- AASTROM BIOSCIENCES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,787,802
- in 7 filings, $5.8M under 10b5-1 plans
Net −$5,787,802. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Mara Joseph Anthony Jr −$4.1M Chief Financial Officer sold 82% of stake
- Flynn Sean C. −$779K Chief Legal Officer sold 88% of stake
- MCLAUGHLIN KEVIN F −$413K Director sold 28% of stake
- ZERBE ROBERT L MD −$386K Director sold 19% of stake
- SIEGAL JONATHAN −$79K Principal Accounting Officer sold 54% of stake
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-10 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −5,625 | $16.81 | $95K | 150,960 |
| 2018-12-10 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −5,625 | 24,375 | ||
| 2018-12-10 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −10,000 | 25,000 | ||
| 2018-12-03 | GILMAN STEVEN C Director | Option exercise | +8,500 | $2.63 | $22K | 8,500 |
| 2018-12-03 | GILMAN STEVEN C Director | Sale | −8,500 | $17.75 | $151K | 0 |
| 2018-12-03 | GILMAN STEVEN C Director | Option exercise · Stock Option (right to buy) | −8,500 | 0 | ||
| 2018-11-12 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +15,000 | $1.95 | $29K | 165,960 |
| 2018-11-12 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −15,000 | $15.90 | $239K | 150,960 |
| 2018-11-12 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −15,000 | 35,000 | ||
| 2018-11-06 | Colangelo Dominick President and CEO | Option exercise | +50,000 | $2.75 | $138K | 125,163 |
| 2018-11-06 | Colangelo Dominick President and CEO | Sale | −50,000 | $15.39 | $770K | 75,163 |
| 2018-11-06 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −50,000 | 150,000 | ||
| 2018-10-15 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +15,000 | $1.95 | $29K | 165,960 |
| 2018-10-15 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −15,000 | $12.65 | $190K | 150,960 |
| 2018-10-15 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise · Stock Option (right to buy) | −15,000 | 50,000 | ||
| 2018-10-04 | Colangelo Dominick President and CEO | Option exercise | +75,000 | $1.95 | $146K | 150,163 |
| 2018-10-04 | Colangelo Dominick President and CEO | Sale | −75,000 | $15.02 | $1.1M | 75,163 |
| 2018-10-04 | Colangelo Dominick President and CEO | Option exercise · Stock Option (right to buy) | −75,000 | 72,188 | ||
| 2018-09-10 | MICHEL GERARD J CFO and VP, Corp. Development | Option exercise | +15,000 | $1.95 | $29K | 165,960 |
| 2018-09-10 | MICHEL GERARD J CFO and VP, Corp. Development | Sale | −15,000 | $12.35 | $185K | 150,960 |
Page 62 of 75 · 1,497 trades